Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: sam who wrote (3722)	2/3/1998 7:16:00 PM
From: Oliver & Co	Read Replies (1) \| Respond to of 6136

"AIDS Deaths Fall Sharply; New Treatments Credited" Washington Post (02/03/98) P. A2 ÿÿÿÿ AIDS deaths in the United States dropped 44 percent during the first half of 1997, largely due to advances in treatment medications.ÿ At the Fifth Conference on Retroviruses and Opportunistic Infections, Centers for Disease Control and Prevention officials announced that U.S. AIDS deaths dropped to 12,040 in the first half of 1997, from 21,460 in the first six months of 1996.ÿ While nationwide data for last year will not be available until July, AIDS death totals in New York City--which has 16 percent of the nation's AIDS cases--are already in and show a 48 percent drop in AIDS deaths in 1997.ÿ The data indicate that all New York City AIDS patients, regardless of race or sex, are benefiting from the new treatments.ÿ Health experts cite improved treatment, particularly the advent of three-drug regimens that include a protease inhibitor, as the reason for the decrease.ÿ The CDC also reported that new AIDS cases fell 12 percent during the first half of 1997.ÿ The agency's Kevin DeCock commented: "We can't see the end of the epidemic, but it is the beginning of a new era."